The invention further comprises a pharmaceutical composition comprising an antibody of {TAIL ~ the invention} or an antigen binding fragment thereof, a nucleic acid molecule of {HEAD ~ the invention}, or an immunogenic polypeptide of the invention, and a pharmaceutically acceptable diluent or carrier 
The invention further comprises a pharmaceutical composition comprising an antibody of { TAIL ~ the invention } or an antigen binding fragment thereof , a nucleic acid molecule of { HEAD ~ the invention } , or an immunogenic polypeptide of the invention , and a pharmaceutically acceptable diluent or carrier
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH